Activin A decreases MPTP and LPS-induced inflammation. by Sandy Stayte (728461)

The presence of cheater cells decreases the resilience of a population. by Alvaro Sanchez (226280)

CsA decreases renal host resistance to UPEC. by Emilie Tourneur (278826)

HC-070 decreases anxiety in a standard EPM. by Stefan Just (4811358)

Leukocyte infiltration <i>in vivo</i> is decreased by CLEC9A inhibition with H37Ra. by An-Chieh Cheng (4532641)

S10 File - by Xiaoshi Jin (15675049)

Treatment with wt- or S360A-(A)PC decreases infarct area. by Karin C. A. A. Wildhagen (599651)

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…VRK1 score was determined by multiplying the VRK1 staining intensity × percentage of VRK1 positive staining. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0203397#pone.0203397.g008" target="_blank">Fig 8A</a> includes the data from all primary tumor and lymph node samples. …”

EQI decreases malonyl-CoA levels in <i>S</i>. <i>aureus</i>. by Erica C. Larson (1344687)

A647D decreased mexiletine sensitivity of P1332L when coexpressed. by Jie Liu (15128)

Progressive decrease in expression of Kcnj10, Kcnq1, Gjb2 and Gjb6 in <i>Spns2^tm1a/tm1a</i> mice. by Jing Chen (4762)

A: Top, representative recording of the application, for 10 seconds, of different concentrations of tribendimidine which produces a depolarization (upward movement of the thickest line) and increase in membrane conductance (decrease in the width of the trace). by Alan P. Robertson (362793)

PIMT decreased the formation of amyloid-like fibrils of H79A alanine substituent of αA66–80 peptides. by Kosuke Magami (10654473)

Decreasing phosphorylation of Moesin, MLC, and Cofilin in border cells without <i>twins</i> function. by Po-An Yeh (210960)

DNMT1 knock down decreases HDAC1 binding to RGS10 promoters in chemoresistant ovarian cancer cells. by Ercan Cacan (393523)

SARS-CoV-2 induced lung inflammation is increased with IL-10 blockade and decreased with IFNγ blockade. by Christine E. Nelson (18946410)

Glucose inhibition decreases IL-1β levels and tumor progression in the B16F10 mouse model. by Yunseo Woo (6157307)

Systemic inhibition of CSF-1R decreases B16F10-induced accumulation of blood monocyte subsets. by Marjolein Sluijter (613087)

Image 10_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

A targeted RNAi screen identifies 17 RNAi candidates that decrease the prolonged lifespan of the METC mutant <i>isp-1;ctb-1</i> by at least 10%. by Ludivine Walter (216669)

“…Among them, 13 represent transcription factors not previously known to function in aging and four (indicated with asterisks) are transcription factors already known to affect lifespan in <i>C. elegans</i>: HSF-1 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Hsu1" target="_blank">[31]</a>, NHR-49 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-VanGilst1" target="_blank">[32]</a>, DAF-16 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Kenyon1" target="_blank">[33]</a>, and PHA-4 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Panowski1" target="_blank">[34]</a>. …”